Condition: Von Willebrand Disease (VWD) · Sponsor: Takeda
The main aim of the study is to evaluate the effectiveness of prophylaxis with vonicog alfa (recombinant von Willebrand factor \[rVWF\]) in children. This study will enroll those participants who have been previously treated with VWF product or with a plasma-derived VWF (pdVWF) product. In this study, participants will be treated with vonicog alfa (rVWF) for 12 months. During the study, participants will visit the study clinic 5 times after treatment initiation.
This description comes directly from the study's public registry record.
Takeda Contact · +1-877-825-3327 · medinfoUS@takeda.com
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham | Birmingham, Alabama, United States | Recruiting |
| Bleeding and Clotting Disorders Institute | Peoria, Illinois, United States | Recruiting |
| Riley Hospital for Children Indiana University Health | Indianapolis, Indiana, United States | Recruiting |
| University of Iowa Hospitals & Clinics PARENT | Iowa City, Iowa, United States | Recruiting |
| Childrens Hospital of Michigan | Detroit, Michigan, United States | Recruiting |
| Michigan State University Center for Bleeding Disorders & Clotting Disorders | East Lansing, Michigan, United States | Recruiting |
| Children's Health Care d/b/a Children's Minnesota | Minneapolis, Minnesota, United States | Recruiting |
| Cure 4 the Kids | Las Vegas, Nevada, United States | Recruiting |
| Rutgers - Robert Wood Johnson Medical School | New Brunswick, New Jersey, United States | Recruiting |
| New York - Presbyterian/Weill Cornell Medical Center | New York, New York, United States | Recruiting |
| Medical University of South Carolina (MUSC) | Charleston, South Carolina, United States | Recruiting |
| Hemostase Clinique - Institut Cœur-Poumons (4eme étage aile est) Bureau 419 | Lille, France | Recruiting |
+ 9 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05582993